Baotou Dongbao Bio-Tech Co Ltd Asset Resilience Ratio

Latest as of December 2023: -1.38%

Baotou Dongbao Bio-Tech Co Ltd asset resilience ratio. Baotou Dongbao Bio-Tech Co Ltd (300239) has an Asset Resilience Ratio of -1.38% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Baotou Dongbao Bio-Tech Co Ltd (300239) defensive interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥-37.84 Million

≈ $-5.54 Million USD Cash + Short-term Investments

Total Assets

CN¥2.74 Billion

≈ $401.24 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Baotou Dongbao Bio-Tech Co Ltd (None–None)

Asset resilience ratio of Baotou Dongbao Bio-Tech Co Ltd from None to None. This chart shows how Baotou Dongbao Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. Read Baotou Dongbao Bio-Tech Co Ltd (300239) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Baotou Dongbao Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Baotou Dongbao Bio-Tech Co Ltd balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-37.84 Million	-1.38%
Total Liquid Assets	CN¥-37.84 Million	-1.38%

Asset Resilience Insights

Limited Liquidity: Baotou Dongbao Bio-Tech Co Ltd maintains only -1.38% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Baotou Dongbao Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Baotou Dongbao Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Baotou Dongbao Bio-Tech Co Ltd Asset Resilience Ratio by Year (None–None)

Baotou Dongbao Bio-Tech Co Ltd asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for Baotou Dongbao Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic

Market Cap

$416.96 Million

CN¥2.85 Billion CNY

Market Cap Rank

#12829 Global

#3738 in China

Share Price

CN¥4.80

Change (1 day)

-0.41%

52-Week Range

CN¥4.52 - CN¥6.63

All Time High

CN¥9.53